Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Actas dermo-sifiliogr. (Ed. impr.) ; 112(2): 134-141, feb. 2021. tab, graf
Article in Spanish | IBECS | ID: ibc-200865

ABSTRACT

En el presente artículo, en base a una revisión de la literatura y su experiencia personal, un equipo multidisciplinar de 14 profesionales sanitarios (incluyendo dermatólogos, reumatólogos, neurólogos, gastroenterólogos, farmacéuticos y enfermeras) ha elaborado una serie de recomendaciones generales y específicas (basadas en la fisiopatología) para el manejo de los efectos adversos secundarios a apremilast que con mayor frecuencia conducen a la suspensión del tratamiento (diarrea, náuseas y cefalea). Se aportan algoritmos sencillos de manejo que incluyen aspectos clínicos de evaluación y sugerencias de tratamiento farmacológico. Los efectos adversos de apremilast pueden ser abordados desde un punto de vista multidisciplinar y la optimización en su manejo pretende proporcionar un beneficio clínico a los pacientes que los sufren


We present a series of general and specific recommendations based on pathophysiologic considerations for managing the most common adverse effects of apremilast that lead to treatment discontinuation: diarrhea, nausea, and headache. The recommendations are based on a review of the literature and the experience of a multidisciplinary team of 14 experts including dermatologists, rheumatologists, neurologists, gastroenterologists, pharmacists, and nurses. We propose a series of simple algorithms that include clinical actions and suggestions for pharmacologic treatment. The adverse effects of apremilast can be managed from a multidisciplinary approach. The purpose of optimizing management is to bring clinical benefits to patients


Subject(s)
Humans , Practice Guidelines as Topic , Thalidomide/analogs & derivatives , Phosphodiesterase 4 Inhibitors/adverse effects , Headache/therapy , Diarrhea/therapy , Nausea/therapy , Disease Management , Headache/chemically induced , Diarrhea/chemically induced , Nausea/chemically induced , Algorithms , Patient Care Team
2.
Arch. Soc. Esp. Oftalmol ; 96(1): 48-51, ene. 2021. ilus
Article in Spanish | IBECS | ID: ibc-200185

ABSTRACT

El propósito de este artículo es describir un caso de agenesia lagrimal congénita unilateral en una niña de 7 años con síntomas oculares, ausencia de secreción lagrimal y una tumoración conjuntival en el ángulo superoexterno del ojo derecho. La agudeza visual era de 20/20 en ambos ojos. El ojo derecho presentaba secreción mucosa, erosiones y filamentos corneales. La anamnesis, la exploración física y las pruebas analíticas descartaron enfermedades sistémicas asociadas a la alacrimia congénita, así como enfermedades reumatológicas, inmunológicas o infecciosas. La resonancia nuclear magnética con diversas técnicas de supresión grasa mostró la ausencia de glándula lagrimal derecha y la presencia de una tumoración compatible con lipoma. Este caso, para nuestro conocimiento, representa la primera comunicación de una agenesia unilateral de glándula lagrimal combinada con un lipoma


The purpose of this report is to describe a case of a unilateral congenital absence of the lacrimal gland in a 7-year-old girl with ocular symptoms, no tear production and a conjunctival tumour at the supero-external angle of the right eye. The visual acuity was 20/20 in both the eyes. The right eye showed mucous secretion, corneal erosions and filaments. Anamnesis, physical examination and clinical tests ruled out systemic diseases associated with congenital alacrima, as well as rheumatic, immunological and infectious diseases. Nuclear magnetic resonance, with various fat suppression techniques, demonstrated the absence of the right lacrimal gland and the presence of a tumour compatible with lipoma. This case, to our knowledge, is the first report of unilateral absence of the lacrimal gland combined with lipoma


Subject(s)
Humans , Female , Child , Lacrimal Apparatus Diseases/congenital , Lacrimal Apparatus Diseases/diagnosis , Lacrimal Apparatus/abnormalities , Salivary Glands/abnormalities , Lipoma/pathology , Visual Acuity , Keratoconjunctivitis Sicca/complications , Magnetic Resonance Spectroscopy , Punctal Plugs , Lubricant Eye Drops/therapeutic use , Hyaluronan Receptors/therapeutic use , Ophthalmic Solutions/therapeutic use , Cyclosporine/therapeutic use
3.
Actas Dermosifiliogr (Engl Ed) ; 112(2): 134-141, 2021 Feb.
Article in English, Spanish | MEDLINE | ID: mdl-32910923

ABSTRACT

We present a series of general and specific recommendations based on pathophysiologic considerations for managing the most common adverse effects of apremilast that lead to treatment discontinuation: diarrhea, nausea, and headache. The recommendations are based on a review of the literature and the experience of a multidisciplinary team of 14 experts including dermatologists, rheumatologists, neurologists, gastroenterologists, pharmacists, and nurses. We propose a series of simple algorithms that include clinical actions and suggestions for pharmacologic treatment. The adverse effects of apremilast can be managed from a multidisciplinary approach. The purpose of optimizing management is to bring clinical benefits to patients.


Subject(s)
Diarrhea/chemically induced , Headache/chemically induced , Nausea/chemically induced , Phosphodiesterase 4 Inhibitors/adverse effects , Thalidomide/analogs & derivatives , Combined Modality Therapy , Diarrhea/diet therapy , Diarrhea/drug therapy , Diarrhea/physiopathology , Disease Management , Headache/drug therapy , Headache/physiopathology , Headache/prevention & control , Humans , Nausea/diet therapy , Nausea/drug therapy , Nausea/physiopathology , Patient Care Team , Phosphodiesterase 4 Inhibitors/therapeutic use , Practice Guidelines as Topic , Psoriasis/drug therapy , Thalidomide/adverse effects , Thalidomide/therapeutic use
4.
Arch Soc Esp Oftalmol (Engl Ed) ; 96(1): 48-51, 2021 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-32600836

ABSTRACT

The purpose of this report is to describe a case of a unilateral congenital absence of the lacrimal gland in a 7-year-old girl with ocular symptoms, no tear production and a conjunctival tumour at the supero-external angle of the right eye. The visual acuity was 20/20 in both the eyes. The right eye showed mucous secretion, corneal erosions and filaments. Anamnesis, physical examination and clinical tests ruled out systemic diseases associated with congenital alacrima, as well as rheumatic, immunological and infectious diseases. Nuclear magnetic resonance, with various fat suppression techniques, demonstrated the absence of the right lacrimal gland and the presence of a tumour compatible with lipoma. This case, to our knowledge, is the first report of unilateral absence of the lacrimal gland combined with lipoma.

5.
Med. integral (Ed. impr) ; 37(7): 297-307, abr. 2001. tab, ilus
Article in Es | IBECS | ID: ibc-7326

ABSTRACT

La xerostomía es la sensación subjetiva de sequedad bucal debido a la disminución de saliva. Puede afectar hasta a un 30 por ciento de la población general.Aunque en sí misma no es una enfermedad, altera la calidad de vida, especialmente en la población anciana.Suele recibir escasa atención, incluso por los propios médicos y, en ocasiones, el mismo paciente no lo refiere hasta que se pregunta directamente por su existencia. Sin embargo, puede ser el síntoma que oriente de la presencia de enfermedad sistémica, como el síndrome de Sjögren. Las causas más frecuentes son el uso de fármacos xerogénicos, la radioterapia cervical y el síndrome de Sjögren. El diagnóstico inicial de la xerostomía se basa en demostrarla mediante sialometría (flujo salival basal) y el diagnóstico diferencial en la combinación de pruebas dinámicas o funcionales que analizan la reserva salival glandular (flujo salival estimulado, gammagrafía salival) y estructurales (biopsia labial). El primer paso del tratamiento se basa en mantener una hidratación adecuada y evitar el uso de fármacos xerogénicos. El uso de saliva artificial y de fármacos sialogogos como la pilocarpina son la base del tratamiento actual de la xerostomía. (AU)


Subject(s)
Humans , Xerostomia/diagnosis , Xerostomia/etiology , Xerostomia/physiopathology , Xerostomia/therapy , Saliva/physiology , Salivary Glands/physiology
6.
Rev Clin Esp ; 187(2): 53-5, 1990 Jun.
Article in Spanish | MEDLINE | ID: mdl-2244057

ABSTRACT

We present 21 cases of visceral Leishmaniasis diagnosed in our hospital during the past 8 years. The diagnostic method used was the visualization of the parasite in bone marrow aspiratory puncture. All cases presented fever at admission, hepatosplenomegaly, anemia elevated sedimentation rate and polyclonal gammapathy. Two of our patients were diagnosed of AIDS during the course of the disease. Cure was observed in all cases after one cycle treatment with pentavalent antimonials except for the two AIDS cases one of whom died due to cerebral toxoplasmosis. We point out visceral Leishmaniasis as an opportunistic infection in patients with AIDS and its resistance to the usual treatment.


Subject(s)
Leishmaniasis, Visceral/epidemiology , Acquired Immunodeficiency Syndrome/complications , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Leishmaniasis, Visceral/complications , Male , Middle Aged , Opportunistic Infections/epidemiology , Retrospective Studies , Spain/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...